Your browser doesn't support javascript.
loading
Machine learning prediction of Gleason grade group upgrade between in-bore biopsy and radical prostatectomy pathology.
Ozbozduman, Kaan; Loc, Irem; Durmaz, Selahattin; Atasoy, Duygu; Kilic, Mert; Yildirim, Hakan; Esen, Tarik; Vural, Metin; Unlu, M Burcin.
Afiliación
  • Ozbozduman K; Bogazici University Physics Department, Istanbul, Turkey. kaan.ozbozduman@boun.edu.tr.
  • Loc I; Bogazici University Physics Department, Istanbul, Turkey.
  • Durmaz S; Department of Radiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Atasoy D; Department of Radiology, University of Koc School of Medicine, Istanbul, Turkey.
  • Kilic M; Department of Urology, VKF American Hospital, Istanbul, Turkey.
  • Yildirim H; Department of Radiology, VKF American Hospital, Istanbul, Turkey.
  • Esen T; Department of Urology, VKF American Hospital, Istanbul, Turkey.
  • Vural M; Department of Urology, University of Koc School of Medicine, Istanbul, Turkey.
  • Unlu MB; Department of Radiology, VKF American Hospital, Istanbul, Turkey.
Sci Rep ; 14(1): 5849, 2024 03 11.
Article en En | MEDLINE | ID: mdl-38462645
ABSTRACT
This study aimed to enhance the accuracy of Gleason grade group (GG) upgrade prediction in prostate cancer (PCa) patients who underwent MRI-guided in-bore biopsy (MRGB) and radical prostatectomy (RP) through a combined analysis of prebiopsy and MRGB clinical data. A retrospective analysis of 95 patients with prostate cancer diagnosed by MRGB was conducted where all patients had undergone RP. Among the patients, 64.2% had consistent GG results between in-bore biopsies and RP, whereas 28.4% had upgraded and 7.4% had downgraded results. GG1 biopsy results, lower biopsy core count, and fewer positive cores were correlated with upgrades in the entire patient group. In patients with GG > 1 , larger tumor sizes and fewer biopsy cores were associated with upgrades. By integrating MRGB data with prebiopsy clinical data, machine learning (ML) models achieved 85.6% accuracy in predicting upgrades, surpassing the 64.2% baseline from MRGB alone. ML analysis also highlighted the value of the minimum apparent diffusion coefficient ( ADC min ) for GG > 1 patients. Incorporation of MRGB results with tumor size, ADC min value, number of biopsy cores, positive core count, and Gleason grade can be useful to predict GG upgrade at final pathology and guide patient selection for active surveillance.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata Límite: Humans / Male Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata Límite: Humans / Male Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido